HFG
BMY icon

Heron Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Heron Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$385K Sell
6,027
-60
-1% -$4.02K 0.21% 99
2023
Q1 		$422K Sell
6,087
-954
-14% -$67.3K 0.23% 90
2022
Q4 		$506K Sell
7,041
-200
-3% -$15.1K 0.34% 63
2022
Q3 		$515K Buy
7,241
+200
+3% +$14.5K 0.32% 72
2022
Q2 		$542K Sell
7,041
-2,060
-23% -$157K 0.33% 73
2022
Q1 		$665K Hold
9,101
– – 0.35% 62
2021
Q4 		$593K Sell
9,101
-145
-2% -$8.51K 0.32% 69
2021
Q3 		$547K Sell
9,246
-10
-0.1% -$659 0.3% 72
2021
Q2 		$618K Sell
9,256
-135
-1% -$8.8K 0.35% 65
2021
Q1 		$591K Buy
9,391
+250
+3% +$15.6K 0.36% 65
2020
Q4 		$570K Sell
9,141
-435
-5% -$26.7K 0.39% 64
2020
Q3 		$567K Sell
9,576
-107
-1% -$6.44K 0.45% 58
2020
Q2 		$556K Sell
9,683
-339
-3% -$20.3K 0.5% 48
2020
Q1 		$602K Sell
10,022
-145
-1% -$8.86K 0.62% 45
2019
Q4 		$681K Buy
+10,167
New +$582K 0.56% 45

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Heron Financial Group's BMY Position: Q2 2023 in Review

Heron Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 0.99% in Q2 2023, selling an estimated $4.02K and leaving 6,027 shares worth $385K. The position accounts for 0.21% of the portfolio, ranked #99.

Heron Financial Group first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. The position peaked at $681K in Q4 2019. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Heron Financial Group held 6,027 shares of Bristol-Myers Squibb worth $385K as of Q2 2023.
  • Heron Financial Group sold 60 Bristol-Myers Squibb shares in Q2 2023, an estimated $4.02K.
  • Bristol-Myers Squibb made up 0.21% of Heron Financial Group's portfolio in Q2 2023, its #99 holding.
  • Heron Financial Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
  • Heron Financial Group's Bristol-Myers Squibb position peaked at $681K in Q4 2019.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.